Legislation to update cosmetics regulations may not have legs in the 115th Congress, but the Independent Cosmetic Manufacturers and Distributors will have an active presence on Capitol Hill regardless. President and CEO Pam Busiek says the small-business trade group will continue working to educate lawmakers on regulatory reform issues while expanding its advocacy work to address tax and trade concerns.
Cosmetics regulatory reform may take a distant back seat to other concerns in the 115th Congress, according to Independent Cosmetic Manufacturers and Distributors leadership, which nevertheless will continue working to educate lawmakers on small business’ stake in proposed legislation.
In an interview with the Rose Sheet, ICMAD President and CEO Pam Busiek noted a “lack of urgency” at present regarding cosmetics oversight modernization, which makes her doubtful that
The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.
Dyes and colors which FDA says industries agree should no longer be used aren’t unsafe and are currently used only with the agency’s approval, industry stakeholders say. Center for Science in the Public Interest says the dyes are used “in tens of thousands of foods and beverages that are commonly consumed here in the United States.”
Testing conducted by the US Food and Drug Administration has found several cosmetic products on the market that contain high levels of methylene chloride, a banned ingredient.
